2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1093894297 MD
Verify on CMS →

LAURIE KANE, MD

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in MANAHAWKIN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
580
Medicare Part D claims · 216 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 611
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$361.9
22 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LAURIE KANE, MD filed 580 Medicare Part D claims in 2023 as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in MANAHAWKIN, New Jersey, prescribing 41% generic.

580
Part D claims, 2023
41%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LAURIE KANE, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

580 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

LAURIE KANE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LAURIE KANE, MD?

Quality data not reported

NPI registry status

Active

Issued 11/06/2006

NPI 1093894297

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

568 US NPIs in this specialty

Medicare Part D claims

580 5% vs specialty avg

2023 prescription claims

Specialty avg: 611

Specialty distribution in New Jersey

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among New Jersey providers

New Jersey providers

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within New Jersey

1. Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician ABMS/AOA estimate

Est. board-certified rate (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LAURIE KANE, MD appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider holding MD credentials at 1100 ROUTE 72 W STE 306B, MANAHAWKIN, NJ, 08050, with a listed phone of (609) 978-3911. NPI 1093894297 was issued on 11/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KANE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 580 prescription claims written by this provider, covering 216 Medicare beneficiaries and totaling roughly $301K in drug spend, split 59% brand-name and 41% generic by claim count, with an opioid prescribing rate of 5.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician is a narrow specialty nationwide, with 568 enrolled providers across 49 states and an average of 611 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1100 ROUTE 72 W STE 306B
MANAHAWKIN, NJ 08050

Provider Details

NPI 1093894297
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials MD
Gender Female
NPI Issued 11/06/2006

Hospital and facility affiliations

Facilities where LAURIE KANE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC
MANAHAWKIN, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LAURIE KANE, MD. Source: openpaymentsdata.cms.gov.

Total received

$362

Largest payer

Sumitomo Pharma America, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

LAURIE KANE, MD — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 580 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

580
Total Claims
$301K
Total Drug Cost
216
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
977
Total Day Supply
26,149
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$292K
Opioid Claims
30 (5.2% rate)
Antibiotic Claims
93

Patient Demographics

Average Patient Age
75.0 years
Avg HCC Risk Score
1.27
Gender Split
100% female / 0% male
Age Distribution
<65: 11, 65-74: 84, 75-84: 99, 85+: 22

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LAURIE KANE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gemtesa
Vibegron
214
Myrbetriq
Mirabegron
107
Cephalexin
42
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
38
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
37
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
29
Solifenacin Succinate
29
Clobetasol Propionate
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How LAURIE KANE, MD fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

568
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
49
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
611
Avg Claims per Provider

LAURIE KANE, MD's 580 claims are below the specialty average of 611.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as KANE.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LAURIE KANE, MD's specialty?
LAURIE KANE, MD specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in MANAHAWKIN, New Jersey. Credentials: MD.
How much does LAURIE KANE, MD prescribe under Medicare Part D?
In 2023, LAURIE KANE, MD wrote 580 Medicare Part D claims totaling $301K in drug costs for 216 beneficiaries.
Where is LAURIE KANE, MD located?
LAURIE KANE, MD is located at 1100 ROUTE 72 W STE 306B, MANAHAWKIN, NJ, 08050. Phone: (609) 978-3911.
What is LAURIE KANE, MD's NPI number?
LAURIE KANE, MD's National Provider Identifier (NPI) is 1093894297, issued on 11/06/2006.
Does LAURIE KANE, MD prescribe more brand-name or generic drugs?
LAURIE KANE, MD's prescribing is 59% brand-name and 41% generic drugs by claim count, with $292K in brand drug costs.
Does LAURIE KANE, MD prescribe opioids?
Yes, LAURIE KANE, MD had 30 opioid claims in 2023 with an opioid prescribing rate of 5.2%.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 568 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 49 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 611 Medicare Part D claims per year.
What drugs does LAURIE KANE, MD prescribe most often?
Based on 2023 Medicare Part D data, LAURIE KANE, MD's most frequently prescribed drugs include Gemtesa, Myrbetriq, Cephalexin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LAURIE KANE, MD accept Medicare?
LAURIE KANE, MD appears in CMS Medicare data with 580 Part D claims and 216 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LAURIE KANE, MD's credentials?
LAURIE KANE, MD's NPI is 1093894297 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology